Finzati - Logo
PLRZ logo

Polyrizon Ltd.

PLRZBiotechnology
Strong market move
PLRZ-10.51%
vs. previous close $12.56
$11.24
-1.32 (-10.51%)
Current price
EarningsLatest report: Dec 31, 2025
HIGHER-RISK PROFILECautionConfidence: 70%

Quantitative profile — not an investment recommendation.

Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Caution is warranted. Recent ratios show weaknesses that may limit returns unless fundamentals improve.
Market Cap
$14.28M
Growth
Cash Flow
0/5
Trend
Negative
Evidence
Manageable debt level · 0Healthy liquidity · 29.03Weak profitability
Financial data as of: Dec 31, 2025, 12:00 AM UTCLast earnings update: Mar 25, 2026, 12:00 AM UTCLast profile update: Aug 5, 2026, 2:27 PM UTC

Company Snapshot

Key valuation, quality, financial strength, momentum and analyst data.

Price$11.24
Change-10.51%
Market Cap$14.28M
52W Range2.88 - 18.20
Beta-1.84
Gross Margin0.00%
Oper. Margin0.00%
Profit Margin0.00%
Debt/Eq0.00
Current Ratio29.03
Quick Ratio29.03
Volume18.71K

Investment DNA

How strong this company looks for long-term investors

47
out of 100
Business Quality
Margins, moat, returns
22/100
Financial Strength
Debt, cash, stability
70/100
Growth Potential
Revenue and expansion
50/100
Price Attractiveness
Cheap or expensive today
95/100
Why this score
Manageable debt level · 0Healthy liquidity · 29.03Weak profitability
Analyst view
No analyst data available now.

Company Overview

IPO: 10/29/2024
Industry: Biotechnology
P/B i: 0.65
Debt / Equity i: 0.00
Operating Margin: 0.00%
Net Margin: 0.00%
ROE i: -
ROIC: -

Financial Health

Score14 / 20
Debt / Equity: 0.00
Current Ratio: 29.03
Quick Ratio: 29.03
Status: Good

Insider Transactions

Recent executive and insider activity

Adler Oz
Transaction: 03/31/2026
SELL
Change
-3,292
Price
$12.05
Filing
04/01/2026
Type
SELL
Carmel Liron
Transaction: 03/31/2026
SELL
Change
-942
Price
$12.36
Filing
04/01/2026
Type
SELL
Izraeli Tomer
Transaction: 03/31/2026
SELL
Change
-500
Price
$11.85
Filing
04/01/2026
Type
SELL